pharmaceutical daily

Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSecond site, Regional…

Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient…

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…

Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and NomineesTORONTO, June 11, 2025 (GLOBE NEWSWIRE)…

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”),…

CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) — Neurodon Corp., a leader in the development of endoplasmic reticulum (ER)…

June 11, 2025 Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a…

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all…

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for…

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for…